Blood Pressure, Autonomic Heart Rate Modulation, Cardiorespiratory Parameters, Functionality and Quality of Life in Hypertensive Women After 16 Weeks of Training Based on the Pilates Method
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hypertension
- Sponsor
- João Luiz Q. Durigan
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Ambulatory blood pressure
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The main objective of this study is to evaluate and compare the effect of the Pilates method associated with aerobic exercise and the traditional Pilates method on the blood pressure of hypertensive medicated women. In addition, we aim to analyze and compare the chronic effects of training on cardiac autonomic modulation, on cardiorespiratory fitness, functionality and quality of life.
Detailed Description
Subjects will be allocated randomly in three groups: (1) Traditional Pilates group, which will perform only exercises based on the traditional Pilates method, (2) Modified Pilates group, which will perform exercises based on the Pilates method alternated with active rest periods on treadmill ergometer, (3) Control group: will not perform any physical exercise during the trial period. The sessions will be performed two times a week, during 16 weeks. Subjects will be evaluated before and after 16 weeks of intervention.
Investigators
João Luiz Q. Durigan
Physical Therapist, Assistant Professor
University of Brasilia
Eligibility Criteria
Inclusion Criteria
- •Hypertensive women
- •Age 30 to 59
- •Sedentary or who do not practice any form of physical exercise regularly for at least 6 months
- •Make use of antihypertensive medication
- •Who have medical clearance for physical exercise
Exclusion Criteria
- •Complaint of pain that influences or makes the performance of the tests / exercises proposed impossible
- •Congenital or acquired anomalies of upper limbs and lower limbs
- •Presence of musculoskeletal disease or injury that interfere the performance of exercises
- •Changes in pharmacological treatment during the experimental period
- •Release for physical activity suspended during intervention
- •Absence in more than 25% of the exercise sessions
Outcomes
Primary Outcomes
Ambulatory blood pressure
Time Frame: Change from Baseline systolic and diastolic Blood Pressure at 16 weeks
Systolic and diastolic blood pressure will be measured by 24-hour Ambulatorial Monitoring Blood Pressure, before and after trial period.
Secondary Outcomes
- Clinical blood pressure(Change from Baseline systolic and diastolic Blood Pressure at 16 weeks)
- Height(Change from Baseline at 16 weeks)
- Body Mass Index(Change from Baseline body mass index at 16 weeks)
- Flexibility(Change from Baseline flexibility at 16 weeks)
- Strength(Change from Baseline strength at 16 weeks)
- Speed to put on and tie his shoes(Change from Baseline speed at 16 weeks)
- Clinical heart rate(Change from Baseline clinical heart rate at 16 weeks)
- Autonomic heart rate modulation(Change from Baseline autonomic heart rate modulation at 16 weeks)
- Body weight(Change from Baseline body weight at 16 weeks)
- Ventilatory threshold measured by the cardiopulmonary exercise test(Change from baseline and at 16 weeks)
- Analysis of the quality of life(Change from Baseline quality of life at 16 weeks)
- Circumference measurements(Change from Baseline circumference measurements at 16 weeks)
- Speed to lift from a sitting position(Change from Baseline speed at16 weeks)
- Speed to lift from a layered position(Change from Baseline speed at 16 weeks)